231 related articles for article (PubMed ID: 30839507)
1. The impact on outcomes by using thiotepa in tandem transplant for pediatric high-risk embryonal brain tumors.
Yen HJ; Yu TY; Lee CY; Hung GY; Chiou TJ; Chen HH; Lee YY; Liang ML; Chen YW
J Chin Med Assoc; 2019 Feb; 82(2):148-154. PubMed ID: 30839507
[TBL] [Abstract][Full Text] [Related]
2. Tandem high-dose chemotherapy with topotecan-thiotepa-carboplatin and melphalan-etoposide-carboplatin regimens for pediatric high-risk brain tumors.
Choi JY; Kang HJ; Hong KT; Hong CR; Lee YJ; Park JD; Phi JH; Kim SK; Wang KC; Kim IH; Park SH; Choi YH; Cheon JE; Park KD; Shin HY
Int J Clin Oncol; 2019 Dec; 24(12):1515-1525. PubMed ID: 31352632
[TBL] [Abstract][Full Text] [Related]
3. High-dose Chemotherapy With Autologous Stem Cell Rescue in Saudi Children Less Than 3 Years of Age With Embryonal Brain Tumors.
Alsultan A; Alharbi M; Al-Dandan S; Bayoumi Y; Alharbi T; Alsudairy R; Alomari A; Aljamaan K; Musleh O; Alharbi Q; Jarrar M
J Pediatr Hematol Oncol; 2015 Apr; 37(3):204-8. PubMed ID: 25551668
[TBL] [Abstract][Full Text] [Related]
4. High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors: the impact of prior radiotherapy on outcome.
Butturini AM; Jacob M; Aguajo J; Vander-Walde NA; Villablanca J; Jubran R; Erdreich-Epstein A; Marachelian A; Dhall G; Finlay JL
Cancer; 2009 Jul; 115(13):2956-63. PubMed ID: 19402050
[TBL] [Abstract][Full Text] [Related]
5. High-dose thiotepa and etoposide-based regimens with autologous hematopoietic support for high-risk or recurrent CNS tumors in children and adults.
Papadopoulos KP; Garvin JH; Fetell M; Vahdat LT; Garrett TJ; Savage DG; Balmaceda C; Bruce J; Sisti M; Isaacson S; De LaPaz R; Hawks R; Bagiella E; Antman KH; Hesdorffer CS
Bone Marrow Transplant; 1998 Oct; 22(7):661-7. PubMed ID: 9818693
[TBL] [Abstract][Full Text] [Related]
6. Changes in glomerular filtration rate and clinical course after sequential doses of carboplatin in children with embryonal brain tumors undergoing autologous stem cell transplantation.
Elborai Y; Almutereen M; Maher OM; Hafez H; Lee MA; Lehmann L
J Egypt Natl Canc Inst; 2020 Feb; 32(1):9. PubMed ID: 32372349
[TBL] [Abstract][Full Text] [Related]
7. Tandem High-dose Chemotherapy without Craniospinal Irradiation in Treatment of Non-metastatic Malignant Brain Tumors in Very Young Children.
Ma Y; Lim DH; Cho H; Lee JW; Sung KW; Yoo KH; Koo HH; Shin HJ; Suh YL
J Korean Med Sci; 2020 Dec; 35(48):e405. PubMed ID: 33316857
[TBL] [Abstract][Full Text] [Related]
8. Phase II Trial Assessing the Ability of Neoadjuvant Chemotherapy With or Without Second-Look Surgery to Eliminate Measurable Disease for Nongerminomatous Germ Cell Tumors: A Children's Oncology Group Study.
Goldman S; Bouffet E; Fisher PG; Allen JC; Robertson PL; Chuba PJ; Donahue B; Kretschmar CS; Zhou T; Buxton AB; Pollack IF
J Clin Oncol; 2015 Aug; 33(22):2464-71. PubMed ID: 26101244
[TBL] [Abstract][Full Text] [Related]
9. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
Thorarinsdottir HK; Rood B; Kamani N; Lafond D; Perez-Albuerne E; Loechelt B; Packer RJ; MacDonald TJ
Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857
[TBL] [Abstract][Full Text] [Related]
10. Topotecan combined with myeloablative doses of thiotepa and carboplatin for neuroblastoma, brain tumors, and other poor-risk solid tumors in children and young adults.
Kushner BH; Cheung NK; Kramer K; Dunkel IJ; Calleja E; Boulad F
Bone Marrow Transplant; 2001 Sep; 28(6):551-6. PubMed ID: 11607767
[TBL] [Abstract][Full Text] [Related]
11. Myeloablative chemotherapy and autologous stem cell transplantation in patients with relapsed or progressed central nervous system germ cell tumors: results of Korean Society of Pediatric Neuro-Oncology (KSPNO) S-053 study.
Baek HJ; Park HJ; Sung KW; Lee SH; Han JW; Koh KN; Im HJ; Kang HJ; Park KD
J Neurooncol; 2013 Sep; 114(3):329-38. PubMed ID: 23824533
[TBL] [Abstract][Full Text] [Related]
12. Phase I study of tandem high-dose chemotherapy with autologous peripheral blood stem cell rescue for children with recurrent brain tumors: a Pediatric Blood and MarrowTransplant Consortium study.
Gilman AL; Jacobsen C; Bunin N; Levine J; Goldman F; Bendel A; Joyce M; Anderson P; Rozans M; Wall DA; Macdonald TJ; Simon S; Kadota RP
Pediatr Blood Cancer; 2011 Sep; 57(3):506-13. PubMed ID: 21744474
[TBL] [Abstract][Full Text] [Related]
13. A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer.
Hu WW; Long GD; Stockerl-Goldstein KE; Johnston LJ; Chao NJ; Negrin RS; Blume KG
Clin Cancer Res; 1999 Nov; 5(11):3411-8. PubMed ID: 10589752
[TBL] [Abstract][Full Text] [Related]
14. Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group.
Finlay JL; Goldman S; Wong MC; Cairo M; Garvin J; August C; Cohen BH; Stanley P; Zimmerman RA; Bostrom B; Geyer JR; Harris RE; Sanders J; Yates AJ; Boyett JM; Packer RJ
J Clin Oncol; 1996 Sep; 14(9):2495-503. PubMed ID: 8823328
[TBL] [Abstract][Full Text] [Related]
15. High-dose thiotepa and etoposide in children with poor-prognosis brain tumors.
Fagioli F; Biasin E; Mastrodicasa L; Sandri A; Ferrero I; Berger M; Vassallo E; Madon E
Cancer; 2004 May; 100(10):2215-21. PubMed ID: 15139067
[TBL] [Abstract][Full Text] [Related]
16. High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors.
Pérez-Martínez A; Lassaletta A; González-Vicent M; Sevilla J; Díaz MA; Madero L
J Neurooncol; 2005 Jan; 71(1):33-8. PubMed ID: 15719272
[TBL] [Abstract][Full Text] [Related]
17. Tandem high-dose chemotherapy and autologous stem cell transplantation in young children with atypical teratoid/rhabdoid tumor of the central nervous system.
Park ES; Sung KW; Baek HJ; Park KD; Park HJ; Won SC; Lim DH; Kim HS
J Korean Med Sci; 2012 Feb; 27(2):135-40. PubMed ID: 22323859
[TBL] [Abstract][Full Text] [Related]
18. Myeloablative Carboplatin and Thiotepa With Autologous Stem Cell Rescue for Nonmedulloblastoma High-risk CNS Tumors in Young Children.
Fries C; Girvin AR; Korones DN; Weintraub L; Fitzpatrick L; Andolina JR
J Pediatr Hematol Oncol; 2021 Nov; 43(8):e1223-e1227. PubMed ID: 34001790
[TBL] [Abstract][Full Text] [Related]
19. Thiotepa/topotecan/carboplatin with autologous stem cell rescue in recurrent/refractory/poor prognosis pediatric malignancies of the central nervous system.
Gilheeney SW; Khakoo Y; Souweidane M; Wolden S; Boulad F; Dunkel IJ
Pediatr Blood Cancer; 2010 Apr; 54(4):591-5. PubMed ID: 19998470
[TBL] [Abstract][Full Text] [Related]
20. Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors.
Gardner SL; Asgharzadeh S; Green A; Horn B; McCowage G; Finlay J
Pediatr Blood Cancer; 2008 Aug; 51(2):235-40. PubMed ID: 18381756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
